STEVEN W SPECTOR Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for STEVEN W SPECTOR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STEVEN W SPECTOR. STEVEN W SPECTOR is EVP, General Counsel & Sec in ARENA PHARMACEUTICALS INC ($ARNA) and Sr. VP, General Counsel & Sec in ARENA PHARMACEUTICALS INC ($ARNA) and SVP, General Counsel & Sec in ARENA PHARMACEUTICALS INC ($ARNA) and VP, General Counsel & Sec in ARENA PHARMACEUTICALS INC ($ARNA).
Latest Insider Trading Transactions of STEVEN W SPECTOR
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 28 2020 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 14.90 | 7,970 | 118,753 | 0 | |
Feb 28 2020 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 14.90 | 7,970 | 118,753 | 17,437 | 9.5 K to 17.4 K (+84.19 %) |
Feb 14 2020 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 37.20 | 4,964 | 184,661 | 2,536 | |
Feb 14 2020 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 32.50 | 2,472 | 80,340 | 1,254 | |
Feb 14 2020 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 55.00 | 10,836 | 595,980 | 9,467 | 20.3 K to 9.5 K (-53.37 %) |
Feb 14 2020 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 37.20 | 4,964 | 184,661 | 20,303 | 15.3 K to 20.3 K (+32.36 %) |
Feb 14 2020 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 32.50 | 2,472 | 80,340 | 15,339 | 12.9 K to 15.3 K (+19.21 %) |
Oct 16 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 0.00 | 6,300 | 0 | 18,900 | |
Oct 16 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Payment of Exercise | F | 47.32 | 3,123 | 147,780 | 12,867 | 16 K to 12.9 K (-19.53 %) |
Oct 16 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 0.00 | 6,300 | 0 | 15,990 | 9.7 K to 16 K (+65.02 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 15.50 | 12,627 | 195,719 | 27,500 | |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 15.50 | 12,627 | 195,719 | 27,500 | |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 15.50 | 12,373 | 191,782 | 40,127 | |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 15.50 | 12,373 | 191,782 | 40,127 | |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 17.90 | 5,810 | 103,999 | 9,189 | |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 17.90 | 5,810 | 103,999 | 9,189 | |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 32.50 | 3,274 | 106,405 | 3,726 | |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 32.50 | 3,274 | 106,405 | 3,726 | |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 50.28 | 12,627 | 634,873 | 9,690 | 22.3 K to 9.7 K (-56.58 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 50.28 | 12,627 | 634,873 | 9,690 | 22.3 K to 9.7 K (-56.58 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 15.50 | 12,627 | 195,719 | 22,317 | 9.7 K to 22.3 K (+130.31 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 15.50 | 12,627 | 195,719 | 22,317 | 9.7 K to 22.3 K (+130.31 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 51.23 | 10,257 | 525,428 | 9,690 | 19.9 K to 9.7 K (-51.42 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 51.23 | 10,257 | 525,428 | 9,690 | 19.9 K to 9.7 K (-51.42 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 50.48 | 21,200 | 1,070,087 | 19,947 | 41.1 K to 19.9 K (-51.52 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 50.48 | 21,200 | 1,070,087 | 19,947 | 41.1 K to 19.9 K (-51.52 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 15.50 | 12,373 | 191,782 | 41,147 | 28.8 K to 41.1 K (+43.00 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 15.50 | 12,373 | 191,782 | 41,147 | 28.8 K to 41.1 K (+43.00 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 17.90 | 5,810 | 103,999 | 28,774 | 23 K to 28.8 K (+25.30 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 17.90 | 5,810 | 103,999 | 28,774 | 23 K to 28.8 K (+25.30 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 32.50 | 3,274 | 106,405 | 22,964 | 19.7 K to 23 K (+16.63 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 32.50 | 3,274 | 106,405 | 22,964 | 19.7 K to 23 K (+16.63 %) |
Feb 04 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 40.10 | 1,500 | 60,150 | 0 | |
Feb 04 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 46.10 | 1,500 | 69,150 | 19,690 | 21.2 K to 19.7 K (-7.08 %) |
Feb 04 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 40.10 | 1,500 | 60,150 | 21,190 | 19.7 K to 21.2 K (+7.62 %) |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | A | 0.00 | 12,600 | 0 | 12,600 | |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | A | 0.00 | 12,600 | 0 | 12,600 | |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | A | 40.94 | 75,000 | 3,070,500 | 75,000 | |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | A | 40.94 | 75,000 | 3,070,500 | 75,000 | |
Aug 17 2018 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 18.10 | 29,005 | 524,991 | 5,525 | |
Aug 17 2018 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 36.69 | 3,943 | 144,676 | 19,690 | 23.6 K to 19.7 K (-16.68 %) |
Aug 17 2018 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 35.90 | 25,062 | 899,829 | 23,633 | 48.7 K to 23.6 K (-51.47 %) |
Aug 17 2018 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 18.10 | 29,005 | 524,991 | 48,695 | 19.7 K to 48.7 K (+147.31 %) |
Apr 18 2018 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 18.10 | 15,000 | 271,500 | 34,530 | |
Apr 18 2018 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 17.90 | 15,001 | 268,518 | 14,999 | |
Apr 18 2018 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 35.81 | 1,400 | 50,135 | 19,690 | 21.1 K to 19.7 K (-6.64 %) |
Apr 18 2018 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 35.00 | 7,700 | 269,467 | 21,090 | 28.8 K to 21.1 K (-26.75 %) |
Apr 18 2018 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 34.33 | 20,901 | 717,456 | 28,790 | 49.7 K to 28.8 K (-42.06 %) |
Apr 18 2018 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 18.10 | 15,000 | 271,500 | 49,691 | 34.7 K to 49.7 K (+43.24 %) |
Apr 18 2018 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 17.90 | 15,001 | 268,518 | 34,691 | 19.7 K to 34.7 K (+76.19 %) |
Mar 06 2018 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Payment of Exercise | F | 42.80 | 3,874 | 165,807 | 19,690 | 23.6 K to 19.7 K (-16.44 %) |
Mar 06 2018 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Grant | A | 0.00 | 11,205 | 0 | 23,564 | 12.4 K to 23.6 K (+90.66 %) |
Jan 22 2018 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | A | 35.60 | 130,000 | 4,628,000 | 130,000 | |
Dec 19 2017 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Payment of Exercise | F | 30.23 | 281 | 8,495 | 12,359 | 12.6 K to 12.4 K (-2.22 %) |
Dec 19 2017 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Payment of Exercise | F | 30.23 | 234 | 7,074 | 12,640 | 12.9 K to 12.6 K (-1.82 %) |
Feb 14 2017 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | A | 1.46 | 1,044,750 | 1,525,335 | 1,044,750 | |
Dec 16 2016 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | A | 1.50 | 342,000 | 513,000 | 342,000 | |
Mar 04 2016 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | A | 1.55 | 525,000 | 813,750 | 525,000 | |
Dec 17 2015 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | A | 1.79 | 300,000 | 537,000 | 300,000 | |
Mar 18 2015 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 1.81 | 4,698 | 8,503 | 495,302 | |
Mar 18 2015 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 1.49 | 65,302 | 97,300 | 79,698 | |
Mar 18 2015 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 5.00 | 70,000 | 350,000 | 128,039 | 198 K to 128 K (-35.35 %) |
Mar 18 2015 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 1.81 | 4,698 | 8,503 | 198,039 | 193.3 K to 198 K (+2.43 %) |
Mar 18 2015 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 1.49 | 65,302 | 97,300 | 193,341 | 128 K to 193.3 K (+51.00 %) |
Jul 03 2012 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 4.01 | 22,300 | 89,423 | 15,001 | |
Jul 03 2012 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 1.49 | 45,000 | 67,050 | 255,000 | |
Jul 03 2012 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 3.25 | 30,000 | 97,500 | 70,000 | |
Jul 03 2012 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 4.01 | 22,699 | 91,023 | 37,301 | |
Jul 03 2012 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 6.00 | 16,666 | 99,996 | 33,334 | |
Jul 03 2012 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 10.05 | 22,300 | 224,115 | 39,588 | 61.9 K to 39.6 K (-36.03 %) |
Jul 03 2012 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 4.01 | 22,300 | 89,423 | 61,888 | 39.6 K to 61.9 K (+56.33 %) |
Jul 03 2012 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 10.04 | 39,365 | 395,134 | 39,588 | 79 K to 39.6 K (-49.86 %) |
Jul 03 2012 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 9.96 | 95,000 | 946,048 | 78,953 | 174 K to 79 K (-54.61 %) |
Jul 03 2012 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 1.49 | 45,000 | 67,050 | 173,953 | 129 K to 174 K (+34.90 %) |
Jul 03 2012 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 3.25 | 30,000 | 97,500 | 128,953 | 99 K to 129 K (+30.32 %) |
Jul 03 2012 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 4.01 | 22,699 | 91,023 | 98,953 | 76.3 K to 99 K (+29.77 %) |
Jul 03 2012 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 6.00 | 16,666 | 99,996 | 76,254 | 59.6 K to 76.3 K (+27.97 %) |
Mar 19 2012 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | A | 1.81 | 500,000 | 905,000 | 500,000 | |
Mar 17 2011 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | Sr. VP, General Cou ... | Option Exercise | A | 1.49 | 300,000 | 447,000 | 300,000 | |
Mar 18 2010 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | SVP, General Counse ... | Option Exercise | A | 3.25 | 100,000 | 325,000 | 100,000 | |
Mar 18 2009 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | SVP, General Counse ... | Option Exercise | A | 4.01 | 60,000 | 240,600 | 60,000 | |
Mar 05 2008 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | SVP, General Counse ... | Option Exercise | A | 6.99 | 60,000 | 419,400 | 60,000 | |
Oct 02 2007 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | SVP, General Counse ... | Sell | S | 11.00 | 10,000 | 110,000 | 53,852 | 63.9 K to 53.9 K (-15.66 %) |
Feb 27 2007 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | SVP, General Counse ... | Option Exercise | A | 13.50 | 60,000 | 810,000 | 60,000 | |
Aug 01 2006 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | SVP, General Counse ... | Option Exercise | A | 10.52 | 10,000 | 105,200 | 10,000 | |
Apr 04 2006 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | SVP, General Counse ... | Buy | J | 3.75 | 625 | 2,344 | 62,284 | 61.7 K to 62.3 K (+1.01 %) |
Jan 24 2006 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | SVP, General Counse ... | Option Exercise | A | 16.80 | 40,000 | 672,000 | 40,000 | |
Jan 24 2006 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | SVP, General Counse ... | Grant | A | 0.00 | 15,000 | 0 | 61,659 | 46.7 K to 61.7 K (+32.15 %) |
Jan 03 2006 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | SVP, General Counse ... | Buy | J | 3.75 | 625 | 2,344 | 46,659 | 46 K to 46.7 K (+1.36 %) |
Oct 03 2005 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | SVP, General Counse ... | Buy | J | 3.75 | 625 | 2,344 | 46,034 | 45.4 K to 46 K (+1.38 %) |
Jul 01 2005 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | SVP, General Counse ... | Buy | J | 3.75 | 420 | 1,575 | 45,409 | 45 K to 45.4 K (+0.93 %) |
Apr 01 2005 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | SVP, General Counse ... | Buy | J | 3.75 | 625 | 2,344 | 44,989 | 44.4 K to 45 K (+1.41 %) |
Jan 18 2005 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | SVP, General Counse ... | Option Exercise | A | 6.16 | 45,000 | 277,200 | 45,000 | |
Jan 04 2005 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | SVP, General Counse ... | Buy | J | 3.75 | 431 | 1,616 | 44,364 | 43.9 K to 44.4 K (+0.98 %) |
Oct 04 2004 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | SVP, General Counse ... | Buy | J | 3.66 | 410 | 1,501 | 43,933 | 43.5 K to 43.9 K (+0.94 %) |
Jul 02 2004 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | SVP, General Counse ... | Buy | J | 4.64 | 323 | 1,499 | 43,523 | 43.2 K to 43.5 K (+0.75 %) |
Jul 02 2004 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | SVP, General Counse ... | Buy | J | 4.64 | 323 | 1,499 | 43,523 | 43.2 K to 43.5 K (+0.75 %) |
Apr 02 2004 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | VP, General Counsel ... | Buy | J | 5.10 | 530 | 2,703 | 43,200 | 42.7 K to 43.2 K (+1.24 %) |
Page: 1